Single and Multiple Ascending Dose Study With EP395
Clinical trial NCT04819854 · COMPLETED
Trial details
- NCT number
- NCT04819854
- Sponsor
- EpiEndo Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-05
- Primary completion
- 2022-03-22
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.